Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Read This First
I2P E-Magazine
The following is a list of suggestions to help you get the most out of the i2P resources on site.
Do not hesitate to communicate with us if you have any enquiry or a suggestion for us to produce a better product.
* Forward your initial email summary received to a range of your colleagues who would be interested in reading i2P E-Magazine.
* Once you are on the site, please use the "Send to a friend" link to pass on valuable information to colleagues and friends.
* Always check that your email filters are set to be "friendly" for i2P deliveries.
Even if you are receiving i2P without problem, still set your filters, because Internet providers can change filter settings or ban specific fileservers if they are unfortunate enough to host a totally unrelated publication that may have been placed on someone's banned list.
If you are having difficulties, please let us know and we will assist you.
* Get adventurous and use new technology in the form of an RSS reader and continually access i2P through importing the RSS link on the home page of the i2P website. If you don't have an RSS reader, get one free at: http://www.feedreader.com/download
* Please feel free to comment on any article by sending an email to the editor neilj@computachem.com.au
* Encourage colleagues to subscribe online at the i2P home page subscription panel.
* Always let us know if you have a particular topic you would like covered.
* Letters to the editor are always encouraged - but there is an alternative at the foot of each article - the "comments" link. This will enable you to comment on any article immediately after reading.
* You can also share interesting material through a range of social links now included as standard for i2P.
* Our archives are open for use as a reference source.
There is an enormous range of contemporary pharmacy content available for students, researchers or business planners.
* Pharmacy organisations - commercial and professional - are invited to contribute news items for publication.
Just simply email the editor at neilj@computachem.com.au with your item, preferably as a Word document and with jpeg graphics separately.
* Readers are reminded that the views expressed by each writer are their own and not necessarily those of the editor, or i2P associated staff.
* Please report any broken links or distorted formatting to neilj@computachem.com.au
* If there is any distortion of text or graphics in your view, please click on this link
http://www.i2p.com.au (best viewed in Internet Explorer 7 or greater or Firefox 2 or greater with minimum desktop resolution of 1024 pixels.
Research Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
